Real-time enrollment status for this atopic dermatitis clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 2:41 PM UTC
| NCT Number | NCT07216027 |
| Recruiting Status | Recruiting |
| Condition | Atopic Dermatitis |
| Phase | PHASE2 |
| Target Enrollment | 165 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | October 13, 2026 (4 days ago) |
As of October 17, 2026: Clinical trial NCT07216027 is currently recruiting participants. This phase2 study for atopic dermatitis is actively seeking new participants at 17 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07216027 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07216027 was last updated 4 days ago (October 13, 2026). HelloStudys verifies this status automatically.